NASDAQ
Cerevel Therapeutics Holdings, Inc. (CERE) has a interest coverage ratio of -42.33x as of Friday, May 29, 2026. This represents a 342.73% decrease compared to its 12-month average of -9.56x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.